The two companies already partner with one another in a number of European countries for the marketing of hydrogen peroxide and peracetic acid product portfolios in the Personal & Health Care market segment.
Both say that the product marketing will be launched in the middle of the year, spanning a total of 25 countries in Europe.
"In Evonik and Brenntag, two companies leading in their market segments come together for the marketing of the new hydrogen peroxide and peracetic acid products", says Michael Träxler, head of the Active Oxygens Business Line in the Resource Efficiency Segment of Evonik Industries.
"With this partnership, we offer our customers access to our specialized product portfolio and can guarantee high reliability and security of supply. All customers from Health Care and Personal Care can continue to rely on us in providing the best suitable products for their applications anywhere in Europe."
The production will be centred on Evonik’s Weißenstein site in Austria, which is currently being certified according to GMP guidelines.
This will make Evonik the first hydrogen peroxide manufacturer in Europe with a fully back integrated production.
"Brenntag and Evonik are ideal partners because together we can guarantee a continuous and reliable production and supply chain for hydrogen peroxide products throughout Europe,” adds Jan Joop Alberts, Marketing Director Specialties at Brenntag Europe, Middle East and Africa.
“Evonik is right in placing its trust in the excellent market expertise, long-term experience, and great customer proximity that Brenntag has established in the European specialty chemicals Business."
Products based on hydrogen peroxide and peracetic acid are used as drug and medical products but also as environment friendly disinfectant and bleaching agents in the Personal & Health Care business.
Evonik has hydrogen peroxide production capacities at twelve sites on six continents.